65°C coffee warning: UAE clinics face new reflux and cancer triage questions

Gulf News reported this week that UAE doctors are warning patients about hot coffee and tea above 65°C, the temperature threshold used by cancer researchers to classify a drink as very hot and linked to higher oesophageal cancer risk.

The practical issue for Dubai clinics is patient triage. The Dubai Health Authority (DHA) has no separate public screening programme for oesophageal cancer comparable with breast, cervical or colorectal screening, so the clinical burden sits with gastroenterology, family medicine and oncology teams when patients present with reflux, dysphagia or unexplained weight loss. In Abu Dhabi and Al Ain, Department of Health Abu Dhabi (DOH) licensed providers face the same referral question. In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, Ministry of Health and Prevention (MOHAP) licensing and facility directories are the relevant checks.

What the 65°C threshold means

The International Agency for Research on Cancer (IARC), part of the World Health Organization, classified very hot beverages above 65°C as probably carcinogenic to humans in 2016. The risk signal concerns temperature damage to the oesophageal lining. It is separate from coffee itself, which IARC did not classify as carcinogenic when consumed below that threshold.

"Drinking very hot beverages was classified as probably carcinogenic to humans." — International Agency for Research on Cancer, IARC news release, 15 June 2016

The latest attention follows an Oxford-led study reported by Cancer Research UK on 9 September 2026. The study examined nearly 980,000 UK adults and found that very hot drink preference was associated with higher risk of oesophageal squamous cell carcinoma, one of the main oesophageal cancer subtypes. The study also reported that people consuming six or more hot drinks a day had higher risk than lower-volume drinkers.

Why this matters for UAE clinics and insurers

For medical directors, the first response should be a symptom-based pathway, rather than a general cancer scare. Patients who drink very hot beverages but have no alarm symptoms need risk counselling. Patients with trouble swallowing, progressive reflux, vomiting blood, black stools, anaemia, persistent chest discomfort after swallowing, or unexplained weight loss need physician assessment and possible upper gastrointestinal endoscopy.

For COOs, the action is to standardise front-desk and call-centre scripts. A patient asking about hot drinks should not be routed automatically to oncology. A patient reporting dysphagia should be routed to gastroenterology or internal medicine within a clinically appropriate timeframe. Dubai providers should verify physician and facility licences through DHA Sheryan. Abu Dhabi providers should check DOH licensing systems, while northern emirate providers should use the MOHAP medical facilities directory.

• Counselling point: advise patients to let coffee, tea or karak cool below the painful or scalding range before drinking.
• Clinical trigger: dysphagia, bleeding symptoms or unexplained weight loss should override reassurance.
• Operational trigger: route alarm symptoms to gastroenterology before oncology unless cancer is already diagnosed.
• Insurance trigger: check referral, network and pre-authorisation rules before booking endoscopy.

For CFOs and insurance teams, the price point is material. The UAE Open Healthcare Directory lists upper GI endoscopy in Dubai at about AED 1,500 to AED 6,000, with a typical price near AED 3,500. Published Dubai clinic pages commonly place gastroenterology consultations in the hundreds of dirhams, while sedated gastroscopy with biopsy can rise when anaesthesia, histology or hospital facility fees are added. Patients insured by Daman, Thiqa or Sukoon should confirm network status and medical-necessity documentation before the procedure, because approval rules differ by policy and emirate.

What operators should do next

There is no UAE regulator announcement requiring a new screening campaign as of 19 September 2026. The near-term task is narrower: update patient education, make the 65°C threshold understandable, and tighten referral rules for upper GI symptoms. Marketing teams should avoid cancer-alarm advertising and publish a simple test: if a drink burns the mouth, wait before swallowing it.

Oncology providers can use the news to improve appropriate referrals. The stronger opportunity sits with gastroenterology, primary care and insurers, because early symptom sorting determines whether a patient receives reassurance, reflux treatment, endoscopy or oncology referral. Patients and operators looking for licensed oncology capacity should start with the UAE Open Healthcare Directory and filter for licensed oncology providers in Dubai, Abu Dhabi and the northern emirates.